Local NewsNational

Actions

Drug companies accused in the opioid epidemic reach $235M settlement before trial

Posted
and last updated

CLEVELAND, Ohio – Four defendants accused in thousands of lawsuits over the opioid epidemic reached a settlement Monday, averting a high-profile trial that was just hours away from starting.

The settlement was reached between four pharmaceutical companies -- McKesson Corp., Cardinal Health Inc, AmerisourceBergen Corp. and Teva Pharmaceutical Industries Ltd. -- and two counties in Ohio, Summit and Cuyahoga counties.

McKesson Corp., Cardinal Health Inc. and AmerisourceBergen Corp. will pay out a combined $215 million immediately, and Teva Pharmaceutical will pay $20 million, officials said at a press conference Monday.

The deal was struck between midnight and 1 a.m. Monday, and the case was dismissed with prejudice, US District Court Judge Dan Polster said.

The defendants were supposed to appear in a Cleveland court Monday in the first federal multidistrict litigation (MDL) trial involving the opioid epidemic.

MDL is similar to class-action lawsuits in the sense that both consolidate plaintiffs' pretrial proceedings, for the sake of efficiency. But unlike with class-action lawsuits, each plaintiff in an MDL case can get a different verdict or award.

The plaintiffs in this MDL case -- Summit and Cuyahoga counties -- were the first among more than 2,700 plaintiff communities to head to trial.

Attorneys general from four states -- North Carolina, Tennessee, Pennsylvania and Texas -- lauded Monday's settlement as "an important step" in combating the opioid epidemic.

"People in every corner of the country have been hurt by this crisis, and it is critical that settlement funds be distributed fairly across states, cities, and counties and used wisely to combat the crisis," the attorneys general said in a joint statement.

"The global resolution we are working to finalize will accomplish those goals while also ensuring that these companies change their business practices to prevent a public health crisis like this from ever happening again."

Both Summit County and Cuyahoga County have announced plans for how settlement awards would be allocated.

Two other defendants were also involved in this case -- a smaller pharmaceutical company, Henry Schein Medical, and the pharmacy chain Walgreens.

Henry Schein Medical will be making a donation of $1 million to establish an educational foundation with Summit County and will pay $250,000 of the county's expenses, the company said in a written statement.

Henry Schein said the plaintiffs have "agreed to dismiss the Company."

Walgreens was not part of the settlement. Judge Polster said claims against the company have been cut off and moved to a different track, with a schedule to follow.

The sudden settlement followed marathon negotiations that went nowhere last week.

The talks lasted more than 10 hours and involved the CEOs of the four major companies; attorneys general from Tennessee, North Carolina, Pennsylvania and Texas' and lawyers representing over 2,000 state, local and Native American tribal governments.

"Our goal when assessing settlement proposals is to provide local communities with adequate and urgently needed relief in the near term, and to ensure that these resources will be directed exclusively toward efforts to abate the opioid epidemic," plaintiffs' attorneys Paul J. Hanly Jr., Paul T. Farrell Jr., and Joe Rice said in a joint statement last week.

"The facts will show that opioid makers and distributors conspired to create and benefit from the worst public health crisis in decades."